{"id":"https://openalex.org/W2028024982","doi":"https://doi.org/10.1111/j.1476-5381.1986.tb11189.x","title":"A further search for selective antagonists at M2\u2010muscarinic receptors","display_name":"A further search for selective antagonists at M2\u2010muscarinic receptors","alternate_titles":[],"publication_year":1986,"publication_date":"1986-12-01","ids":{"openalex":"https://openalex.org/W2028024982","doi":"https://doi.org/10.1111/j.1476-5381.1986.tb11189.x","mag":"2028024982","pmid":"https://pubmed.ncbi.nlm.nih.gov/3814912","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1917221"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1986.tb11189.x","doi":"https://doi.org/10.1111/j.1476-5381.1986.tb11189.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1986.tb11189.x","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2028024982"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1917221/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003362492","display_name":"Richard B. Barlow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R.B. Barlow","raw_affiliation_strings":["Department of Pharmacology, Medical School, University Walk, Bristol BS8 1TD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Medical School, University Walk, Bristol BS8 1TD","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027269690","display_name":"Michael K. Shepherd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M.K. Shepherd","raw_affiliation_strings":["Department of Pharmacology, Medical School, University Walk, Bristol BS8 1TD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Medical School, University Walk, Bristol BS8 1TD","institution_ids":["https://openalex.org/I36234482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I36234482"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.3467,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.80553185,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"89","issue":"4","first_page":"837","last_page":"843"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/m2-muscarinic-receptor","display_name":"M2 muscarinic receptor","score":0.8539999723434448},{"id":"https://openalex.org/keywords/antimuscarinic-agents","display_name":"antimuscarinic agents","score":0.8330000042915344},{"id":"https://openalex.org/keywords/procyclidine","display_name":"procyclidine","score":0.9829999804496765},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.7210000157356262},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8100000023841858},{"id":"https://openalex.org/keywords/carbachol","display_name":"carbachol","score":0.8709999918937683},{"id":"https://openalex.org/keywords/guinea-pig-atria","display_name":"guinea pig atria","score":0.7680000066757202},{"id":"https://openalex.org/keywords/ileum","display_name":"ileum","score":0.8349999785423279}],"concepts":[{"id":"https://openalex.org/C33789571","wikidata":"https://www.wikidata.org/wiki/Q410959","display_name":"Muscarinic acetylcholine receptor","level":3,"score":0.8166207075119019},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.799933910369873},{"id":"https://openalex.org/C2778988552","wikidata":"https://www.wikidata.org/wiki/Q419401","display_name":"Carbachol","level":3,"score":0.6589353084564209},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6299046874046326},{"id":"https://openalex.org/C201194858","wikidata":"https://www.wikidata.org/wiki/Q898238","display_name":"Steric effects","level":2,"score":0.6131234169006348},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5842658281326294},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5717213153839111},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.47428756952285767},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18268269300460815},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007082","descriptor_name":"Ileum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007082","descriptor_name":"Ileum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009130","descriptor_name":"Muscle, Smooth","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009130","descriptor_name":"Muscle, Smooth","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009200","descriptor_name":"Myocardial Contraction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009206","descriptor_name":"Myocardium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010277","descriptor_name":"Parasympathomimetics","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010277","descriptor_name":"Parasympathomimetics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011976","descriptor_name":"Receptors, Muscarinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1986.tb11189.x","doi":"https://doi.org/10.1111/j.1476-5381.1986.tb11189.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1986.tb11189.x","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:3814912","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3814912","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1917221","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1917221/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1917221","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1917221/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.504800021648407}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W618812625","https://openalex.org/W1650621942","https://openalex.org/W1968324214","https://openalex.org/W1971969772","https://openalex.org/W2077487295","https://openalex.org/W2313580853","https://openalex.org/W2319430711","https://openalex.org/W2326004510","https://openalex.org/W2576553726","https://openalex.org/W4250748882"],"related_works":["https://openalex.org/W2077487295","https://openalex.org/W2020203262","https://openalex.org/W2082346121","https://openalex.org/W2011009404","https://openalex.org/W2033970938","https://openalex.org/W2015981601","https://openalex.org/W2079951203","https://openalex.org/W1981366981","https://openalex.org/W6989079627","https://openalex.org/W2064344156"],"abstract_inverted_index":{"In":[0],"an":[1],"attempt":[2],"to":[3,83,113,117],"obtain":[4],"more":[5,136],"selective":[6,137],"antagonists":[7],"acting":[8],"at":[9,38,44],"muscarinic":[10],"M2-receptors,":[11],"analogues":[12],"of":[13,125],"4-diphenylacetoxy-N-methylpiperidine":[14],"methobromide":[15,102],"(4-DAMP":[16],"methobromide)":[17],"have":[18],"been":[19],"synthesized.":[20],"These":[21],"were":[22],"tested,":[23],"along":[24],"with":[25,34,130],"silabenzhexol,":[26],"procyclidine,":[27],"sila-procyclidine":[28],"and":[29,42,48,56,71,86],"AFDX-116,":[30],"in":[31,69,76],"dose-ratio":[32],"experiments":[33],"guinea-pig":[35],"isolated":[36],"atria":[37],"30":[39,45],"degrees":[40,46,50],"C":[41,47],"ileum":[43,70],"37":[49],"C.":[51],"The":[52,78],"agonist":[53],"was":[54,59,80],"carbachol":[55],"the":[57,62,84,126],"selectivity":[58,79,93,99],"assessed":[60],"from":[61],"difference":[63],"between":[64],"log":[65,72],"K":[66,73],"for":[67,74],"receptors":[68,75],"atria.":[77],"not":[81],"related":[82],"affinity":[85,118],"some":[87],"weakly":[88],"active":[89],"compounds":[90],"retained":[91],"appreciable":[92],"but":[94,119],"no":[95,122],"compound":[96],"had":[97],"greater":[98],"than":[100],"4-DAMP":[101],"or":[103],"pentamethylene":[104],"bis-(4-diphenylacetoxy-N-methylpiperidinium)":[105],"bromide.":[106],"Structure-activity":[107],"relations":[108],"are":[109,121],"discussed.":[110],"There":[111],"seem":[112],"be":[114,140],"steric":[115],"limits":[116],"there":[120],"obvious":[123],"indications":[124],"structural":[127],"features":[128],"associated":[129],"selectivity.":[131],"It":[132],"is":[133],"suggested":[134],"that":[135],"drugs":[138],"may":[139,146],"obtained":[141],"by":[142],"introducing":[143],"groups":[144],"which":[145],"reduce":[147],"affinity.":[148]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2028024982","counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
